WILLIAM PEARSON: Open Payments
NPI 1972758480 · SNOW HILL, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$317 in 16 payments from 10 companies in 2025. Trend: 2023 $361 · 2024 $372 · 2025 $317
Food & beverage: $317
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 5 | $141 |
| GlaxoSmithKline, LLC. | 2 | $34 |
| ABBVIE INC. | 2 | $32 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $19 |
| Insulet Corporation | 1 | $16 |
| Currax Pharmaceuticals LLC | 1 | $16 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $16 |
| Exact Sciences Corporation | 1 | $16 |
| Abbott Laboratories | 1 | $14 |
| Corcept Therapeutics | 1 | $14 |
Products named: AIRSUPRA, TRELEGY ELLIPTA, QULIPTA, JARDIANCE, BREZTRI, Omnipod, CONTRAVE, XIFAXAN.
Industry payments across NC — which companies pay providers there.
